Yatsen Holding Ltd (YSG): Shareholders' Equity

Annual figures by period end, from SEC filings.

3.00B CNY
As of 2025-12-31
-14.0%
3-year compound annual growth
-15.3%
5-year compound annual growth
6.86B CNY2018-12-31: -58.48M CNY2019-12-31: -55.80M CNY2020-12-31: 6.86B CNY2021-12-31: 5.67B CNY2022-12-31: 4.72B CNY2023-12-31: 4.13B CNY2024-12-31: 3.05B CNY2025-12-31: 3.00B CNY3.00B CNY
2018-12-31 Shareholders' Equity (CNY) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-313.00B CNY-1.7%2026-04-29, Balance as of period end
2024-12-313.05B CNY-26.2%2026-04-29, Balance as of period end
2023-12-314.13B CNY-12.5%2026-04-29, Balance as of period end
2022-12-314.72B CNY-16.7%2025-04-22, Balance as of period end
2021-12-315.67B CNY-17.4%2024-04-26, Balance as of period end
2020-12-316.86B CNYn/m2023-04-26, Balance as of period end
2019-12-31-55.80M CNYn/m2022-04-22, Balance as of period end
2018-12-31-58.48M CNYn/a2021-04-21, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Perfumes, Cosmetics & Other Toilet Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Yatsen Holding Ltd (YSG)2025-12-313.00B CNY-1.7%
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-31306.71M CNY-13.0%

Compare YSG, ZYBT side by side · Screen every company in Perfumes, Cosmetics & Other Toilet Preparations ↗